The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Anxiety in Parkinson's disease: identification and management
Open accessAbstract
Anxiety disturbances are recognized as common psychiatric comorbidities in Parkinson’s disease (PD) and contribute to significant impairments in areas of cognitive, functional, motor and social performance. Anxiety in PD results in reduced quality of life, higher levels of care dependency and increased caregiver burden. Surprisingly, there is a paucity of treatment data. In one randomized, controlled study, bromazepam was found to be effective for anxiety in PD. However, usage of benzodiazepines in the PD population is limited by potential risk of confusion and falls. There are no controlled studies of selective serotonin reuptake inhibitors (SSRIs) for anxiety in PD. However, results from uncontrolled studies suggest that SSRIs are effective for anxiety in PD, although in these studies anxiety outcomes were secondary. This review underscores that, given the high prevalence of anxiety disturbances in PD, there is a significant paucity of treatment data for this population. Additional studies are warranted. In the meantime, clinicians should rely on empiric assessments of known risks and putative benefits to guide treatment decisions. Cognitive and behavioral therapies (with or without pharmacotherapy) have demonstrated efficacy and warrant consideration. When feasible, a targeted and individualized multimodal approach utilizing psychotherapeutic interventions along with pharmacologic therapies should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“concerns regarding unfavorable side effects, including exacerbation of motor problems in patients with complex medication regimes, have been noted (Rabinstein and Shulman, 2000”
From Remote delivery of psychological interventions for Parkinson's disease. (2018) · cites this paper as Chen and Marsh, 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Parkinson, J. (2002) · Journal of Neuropsychiatry · doi:10.1176/jnp.14.2.223 · Cited by 2,856
Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,090
Drug Facts and Comparisons 1991.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-823_1 · Cited by 776
Non-recognition of depression and other non-motor symptoms in Parkinson's disease
Shulman, L. M., Taback, R. L., Rabinstein, A. A., & Weiner, W. J. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00015-3 · Cited by 695
Nonmotor fluctuations in Parkinson’s disease: Frequent and disabling
Witjas, T., Kaphan, E., Azulay, J. P., Blin, O., Ceccaldi, M., Pouget, J., Poncet, M., & Chérif, A. A. (2002) · Neurology · doi:10.1212/wnl.59.3.408 · Cited by 642
Factors impacting on quality of life in Parkinson's disease: Results from an international survey
The Global Parkinson's Disease Survey (GPDS) Steering Committee (2002) · Movement Disorders · doi:10.1002/mds.10010 · Cited by 524
Gallagher, D. A., Lees, A. J., & Schrag, A. E. (2010) · Movement Disorders · doi:10.1002/mds.23394 · Cited by 506
Research works printed but not linked: 6
- Black K., 2000, J Psychiatry Neurosci, 25, 255
- Casacchia M., 1975, Riv Neurol, 45, 326
- Hanna K., 2012, Parkinsons Dis, 2012, 640707
- Kano O., 2011, Parkinsons Dis, 2011, 143547
- Richard I., 2004, Cogn Behav Neurol, 17, 201
- Shulman L., 1996, Mov Disord, 11, 12
Cited by
Sorted by citations
Items 101–160 of 160
Anxiety in Parkinson’s Patients: What’s Timing Got to Do with It?
DeMarco, E. C., Zhang, Z., Robinson, H., & Hinyard, L. (2023) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887231163293 · Cited by 5
Neurobehavioral Issues in Adult Neurological Conditions
Malarmathi, S., Safeekh, A., & Joshua, A. M. (2022) · Springer eBooks · doi:10.1007/978-981-19-0209-3_15 · Cited by 4
Couto, S. D. F., Araújo, S. M., Bortolotto, V. C., Dahleh, M. M. M., Musachio, E. A. S., Pinheiro, F. C., Romio, L. C., Sacramento, M., Alves, D. A. C., & Prigol, M. (2022) · New Journal of Chemistry · doi:10.1039/d2nj04011e · Cited by 4
Do Benzodiazepines Impair Motor and Nonmotor Symptoms in a Sample of Parkinson’s Disease Patients?
Gaztanaga, W., Sarno, M., Margolesky, J. H., Luca, C. C., Singer, C., Moore, H. P., Jagid, J. R., & Levin, B. E. (2021) · Cureus · doi:10.7759/cureus.13220 · Cited by 4
Košutzká, Z., Kušnírová, A., Hajdúk, M., Straka, I., Minár, M., & Valkovič, P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01024 · Cited by 4
Feehan, S., & Kritzer, M. F. (2025) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2025.1646733 · Cited by 3
Mehdizadeh, M., Eissazade, N., Fereshtehnejad, S.-M., Shati, M., Mortazavi, S. S., Habibi, S. A. H., Bayat, M., Fendereski, F., Akbari, R., Sharabiani, P. T. A., et al. (2025) · Clinical Gerontologist · doi:10.1080/07317115.2025.2555573 · Cited by 3
Paranoia and unusual sensory experiences in Parkinson’s disease
Brown, P., Freeman, D. H., Loe, B. S., Dow, R., & Johns, L. (2025) · Aging & Mental Health · doi:10.1080/13607863.2025.2450258 · Cited by 3
The complexities of advance care planning in patients with idiopathic Parkinson's disease
Mace, C. Z. (2017) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2017.13.4.178 · Cited by 3
Coleman, A. A., Driver, C., Parker, J. K., & Lovell, G. (2019) · Nursing and Health Sciences · doi:10.1111/nhs.12625 · Cited by 3
Hyper-serotonergic state determines onset and progression of idiopathic Parkinson’s disease
Moreira-Junior, E. D. C. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109399 · Cited by 3
How far can I reach? The perception of upper body action capabilities in Parkinson’s disease
Readman, M. R., McLatchie, N. M., Poliakoff, E., Crawford, T. J., & Linkenauger, S. A. (2021) · Attention Perception & Psychophysics · doi:10.3758/s13414-021-02340-y · Cited by 2
Anxiety Symptoms and Disease Severity in Parkinson Disease
Whitmarsh, A., Protea, S., & Gibson, J. S. (2024) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000770 · Cited by 2
Concept Analysis of Anxiety in Patients with Unruptured Intracranial Aneurysm
Lee, J. E., & Lee, S. J. (2022) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2022.34.1.85 · Cited by 2
McGlasson, T. D. (2016) · Adultspan Journal · doi:10.1002/adsp.12018 · Cited by 2
Validation of the Distress Thermometer in Parkinson's disease
Reynolds, B., O’Connell, S., & Cullen, B. (2022) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.769 · Cited by 2
The contribution of cognitive behavioural factors to social anxiety in Parkinson’s disease
Nash, K., Dysch, L., Jones, J. T., MacQueen, R., & Marks, E. M. (2021) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465821000291 · Cited by 2
Pachana, N. A., & Byrne, G. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781139087469.014 · Cited by 1
Herath, H. M. M. T. B., Wijayawardhana, S., Wickramarachchi, U. I., Senanayake, S., Rodrigo, C., & Senanayake, B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312342 · Cited by 1
Joseph, J. H. M., Irakkam, M. P. B. D., & Kandasamy, M. (2025) · Brain Sciences · doi:10.3390/brainsci15090916 · Cited by 1
Chou, S. C., Cong, C., Brownson-Smith, R., Milne‐Ives, M., & Meinert, E. (2026) · Communications Medicine · doi:10.1038/s43856-025-01304-9 · Cited by 2
Albrecht, F., Conklin, S. J., Hooyman, A., Peterson, D. S., Longhurst, J. K., & Franzén, E. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01357-0 · Cited by 1
Molecular Mechanisms and Potential Biomarkers of Neuropsychiatric Disorders in Parkinson’s Disease
Owecki, W., Futyma, A., Kokorniak, O., Szczech, A., Słowikowski, B. K., Poszwa, J., Szymanowicz, O., Goutor, U., Jagodziński, P. P., Kozubski, W. P., et al. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin50055 · Cited by 1
Anxiety in Parkinson’s Disease
Dissanayaka, N. N. (2021) · Cambridge University Press eBooks · doi:10.1017/9781139087469.009 · Cited by 1
Castelpietra, G., Balestrieri, M., Brusaferro, S., & Arnoldo, L. (2022) · Epidemiology Biostatistics and Public Health · doi:10.2427/13157 · Cited by 1
Desai, A. K., & Grossberg, G. T. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316687024.008
Parkinson's disease: a focus on policy for 2017
Thomas, S. (2017) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2017.13.5.232
Affective and personality disorders in Parkinson's disease premotor phase. Pilot study.
Samushiya, M. A., Ragimova, A. A., Геннадьевна, С. И., M.Yu., M., & Ivannikova, E. I. (2020) · Cognitive Remediation Journal · doi:10.5507/crj.2020.001
TAILORING DIGITAL HEALTH TO IMPROVE THE NUTRITION AND HEALTH OF PEOPLE WITH PARKINSON’S DISEASE
LoBuono, D. L. (2020) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-lobuono-dara-2020
Common Psychiatric Disorders in Long-Term Care
Desai, A. K., & Grossberg, G. T. (2017)
Clinical Trials for Depression, Anxiety, Fatigue, and Apathy in Parkinson’s Disease
Škorvánek, M., & Baláž, M. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_10
Assessing health related quality of life and distress in people with Parkinson’s Disease
Reynolds, B. (2021) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.81890
Fourie, L. L. (2020) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Lam, Y.-S., Liu, X., Ke, Y., & Yung, W. (2022) · Network Neuroscience · doi:10.1162/netn_a_00251
Parkinson’s Disease and Atypical Parkinsonian Syndromes
Ridgeway‐Diaz, J. G., & Marsh, L. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574317.003.0017
Self-citationAdu, T. S., Adu, O., & Mabandla, M. V. (2022) · Surgical Research · doi:10.33425/2689-1093.1043
The Neurology–Psychiatry Interface
Clark, A., & Thomasson, R. (2023) · Cambridge University Press eBooks · doi:10.1017/9781911623533.012
Neuropsychiatric Manifestations in Parkinson’s Disease and Other Lewy Body Diseases
Park, K.-W. (2024) · Springer eBooks · doi:10.1007/978-981-97-1821-4_16
Sadek, A. T., Djerdjour, L., Reyes, R., Adams, G. P., Logan, C. H., Smith, M. A., Biddle, S., Wiles, T. S., Urrea‐Mendoza, E., McConnell, T. M., et al. (2024) · Neurology and Therapy · doi:10.1007/s40120-024-00636-3
Frucht, S. J., & Termsarasab, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-52573-5_2
DBS in Parkinson patients with psychiatric symptoms
Beudel, M., Rutten, S., Namavar, Y., & van den Heuvel, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18910-4.00014-4
Studying Neuropsychiatric Symptoms, Depression, Anxiety in Parkinson’s Disease
Kayser, S., & Groppa, S. (2024) · Neuromethods · doi:10.1007/978-1-0716-4083-8_6
Using Bivariate Latent Growth Model to Better Understand the Anxiety Symptom in Parkinson's PatientsPreprint
Wang, Q., Li, P., Sun, Y., Shi, Y., Bian, J., & Zhao, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4925629/v1
Psychological Challenges of Parkinson’s Disease: Unraveling Catastrophizing, Anxiety, and Depression
Rider, J. V. (2024) · Springer eBooks · doi:10.1007/978-3-031-32046-0_48-1
Incidence of antiepileptic drug use in Parkinson's disease
Tuominen, S., Tiihonen, M., Paakinaho, A., Koponen, M., Kaasinen, V., Hartikainen, S. A., & Tolppanen, A. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251343079
Akan, M., ÇIPLAK, S., & Adıgüzel, A. (2025) · Neurology India · doi:10.4103/neurol-india.neurol-india-d-24-00415
Psychological Challenges of Parkinson’s Disease: Unraveling Catastrophizing, Anxiety, and Depression
Rider, J. V. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_48
Craig, G. E., Mehta, N. D., Bekhbat, M., Revill, K. P., Lucido, M. J., Changdo, H., Wommack, E. C., Baer, W. M., Haroon, E., Miller, A. H., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106252 · Cited by 1
Role of synaptic zinc in pathophysiology of Parkinson’s disease
Sikora, J. (2020) · theses.fr (ABES) · doi:10.70675/87e4f747zbcf8z45aaz8541z50965800f3c6
Prise en charge thérapeutique de la maladie de Parkinson
Devos, D., Marchand, F., Bayen, S., & Moreau, C. (2026) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2026.100790
Identifying Predictors of Discordance Between Balance Perception and Ability in Parkinson Disease
Conklin, S. J., Albrecht, F., Hooyman, A., Peterson, D., Franzén, E., & Longhurst, J. K. (2026) · Neurology Report · doi:10.1097/npt.0000000000000556
Tian, Y., Guo, W., Tian, Y., & Shan, Q. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115360
Yates, J. R. (2026) · Springer eBooks · doi:10.1007/978-3-032-15602-0_8
Incidence of anxiety disorders following Parkinson’s disease: a population-based cohort study
Bae, Y., Han, J., Jeon, S. R., Shin, W., Dong, J. J., Jung, H., & Lee, S. W. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1788684
Bouchetara, M. S., & Chentouf, A. (2026) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2026.03.008
Pedak, K., Toomsoo, T., Margato, M. I. D. M. C. O., & Pehk, A. (2026) · Journal of Physical Medicine and Rehabilitation · doi:10.33696/rehabilitation.8.065
Tseng, K.-Y., Kuo, T., Chang, P.-K., Chou, J.-L., Huang, E. Y., Greig, N. H., Choi, H.-I., Olson, L., Hoffer, B. J., & Chen, Y.-H. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261477621
Metadata
- Authors
- Chen, J. J., & Marsh, L.
- Affiliations
- Loma Linda University (US)
- Michael E. DeBakey VA Medical Center (US)
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2013-07-17
- Volume
- 7
- Issue
- 1
- Pages
- 52-59
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- PMC
- PMC3886380
- OpenAlex
- W2149341227
- Cited by
- 161
- References
- 69
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 18 · 2023: 10 · 2022: 17 · 2021: 20 · 2020: 15 · 2019: 15 · 2018: 7 · 2017: 8 · 2016: 10 · 2015: 10 · 2014: 5
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Therapeutic Advances in Neurological Disorders (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, anxiety, psychiatric comorbidity, benzodiazepines, bromazepam, selective serotonin reuptake inhibitors, multimodal therapy, quality of life, caregiver burden, fall risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
